Back to WA WOLVERINE ASSET MANAGEMENT LLC

APAPELLIS PHARMACEUTICALS INC

Showing 7 of 22 quarters

Position history for WAWOLVERINE ASSET MANAGEMENT LLC's holdings in APELLIS PHARMACEUTICALS INC

No. Wolverine Asset Management exited its APELLIS PHARMACEUTICALS position in Q2 2026. Its Q1 2026 13F listed 3,122,000 shares worth $3.3M. Wolverine Asset Management first reported APELLIS PHARMACEUTICALS in Q3 2020 and held it in 20 quarterly 13F filings.

Final Value

$0

Final Shares

0

Total Value Change

-$3.1M

Total Shares Change

-2.7M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Exited
0
-100.0%
$00.0%—
0
2026-Q1
Unchanged
3.1M
0.0%
$3.3M0.0%—
0
2025-Q4
Unchanged
3.1M
0.0%
$3.2M0.0%—
0
2025-Q3
Increased
3.1M
+5.2%
$3.2M0.0%—
28
2025-Q2
Unchanged
3M
0.0%
$3M0.0%—
0
2025-Q1
Increased
3M
+11.3%
$3.1M0.0%—
29
2024-Q4
New
2.7M
—
$3.1M0.0%—
37

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used